XZR reduced the degranulation of mast cells as well as the levels of CGRP, SP, NO, and proinflammatory cytokines, including TNF-α, IL-1β, and IL-6, suggesting that XZR improved migraine by relieving the neurogenic inflammatory response. The gene discussed is TFF2; the disease is migraine disorder.